{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:11:24Z","timestamp":1782922284770,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-NS30652"],"award-info":[{"award-number":["R01-NS30652"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006379","name":"Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006379","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.expneurol.2004.05.006","type":"journal-article","created":{"date-parts":[[2004,6,17]],"date-time":"2004-06-17T13:05:21Z","timestamp":1087477521000},"page":"195-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Extending the window for acute stroke treatment: thrombolytics plus CNS protective therapies"],"prefix":"10.1016","volume":"188","author":[{"given":"Kenneth R.","family":"Wagner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward C.","family":"Jauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2004.05.006_BIB1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1197\/aemj.10.7.805","article-title":"The Society for Academic Emergency Medicine position on optimizing care of the stroke patient","volume":"10","author":"Adams","year":"2003","journal-title":"Acad. Emerg. Med"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB2","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1161\/01.STR.0000068170.80517.B3","article-title":"Ethanol plus caffeine (caffeinol) for treatment of ischemic stroke: preclinical experience","volume":"34","author":"Aronowski","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB3","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/00004647-200003000-00002","article-title":"Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats","volume":"20","author":"Asahi","year":"2000","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB4","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1021\/ja011507s","article-title":"Stilbazulenyl nitrone (STAZN): a nitronyl-substituted hydrocarbon with the potency of classical phenolic chain-breaking antioxidants","volume":"124","author":"Becker","year":"2002","journal-title":"J. Am. Chem. Soc"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.expneurol.2003.10.008","article-title":"Hypothermia and brain-derived neurotrophic factor reduce glutamate synergistically in acute stroke","volume":"185","author":"Berger","year":"2004","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00004647-200101000-00002","article-title":"Reactive oxygen radicals in signaling and damage in the ischemic brain","volume":"21","author":"Chan","year":"2001","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB7","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.STR.32.3.748","article-title":"Comparison of TNK with wild-type tissue plasminogen activator in a rabbit embolic stroke model","volume":"32","author":"Chapman","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB8","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/01.STR.0000061885.90999.A9","article-title":"New research in the field of stroke: therapeutic hypothermia after cardiac arrest","volume":"34","author":"Dietrich","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/clc.4960240903","article-title":"Issues in the assessment of the safety and efficacy of tenecteplase (TNK-tPA)","volume":"24","author":"Gibson","year":"2001","journal-title":"Clin. Cardiol"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/01.STR.0000048846.09677.62","article-title":"Adventures in the pathophysiology of brain ischemia: penumbra, gene expression, neuroprotection: the 2002 Thomas Willis lecture","volume":"34","author":"Ginsberg","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB11","first-page":"189","article-title":"Therapeutic modulation of brain temperature: relevance to ischemic brain injury","volume":"4","author":"Ginsberg","year":"1992","journal-title":"Cerebrovasc. Brain Metab. Rev"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/ana.10659","article-title":"Stilbazulenyl nitrone, a novel antioxidant, is highly neuroprotective in focal ischemia","volume":"54","author":"Ginsberg","year":"2003","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharmthera.2003.07.003","article-title":"Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059","volume":"100","author":"Green","year":"2003","journal-title":"Pharmacol. Ther"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB14","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(98)08020-9","article-title":"Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators","volume":"352","author":"Hacke","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB15","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0140-6736(04)15692-4","article-title":"Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials","volume":"363","author":"Hacke","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB16","first-page":"273","article-title":"\u03b1(Phenyl-tert-butylnitrone protects the oxidatively sensitive enzyme creatine kinase in experimental intracerebral hemorrhage","volume":"29","author":"Hall","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB17","first-page":"673","article-title":"Protein oxidation and enzyme susceptibility in white and gray matter with in vitro oxidative stress: relevance to brain injury from intracerebral hemorrhage","volume":"46","author":"Hall","year":"2000","journal-title":"Cell. Mol. Biol"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0074-7742(08)60725-4","article-title":"Nitrone-based free radical traps as neuroprotective agents in cerebral ischaemia and other pathologies","volume":"40","author":"Hensley","year":"1997","journal-title":"Int. Rev. Neurobiol"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1197\/j.aem.2003.09.007","article-title":"Society for Academic Emergency Medicine (SAEM) Neurologic Emergencies Interest Group response to the SAEM board position on optimizing care of the stroke patient","volume":"11","author":"Jauch","year":"2004","journal-title":"Acad. Emerg. Med"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB20","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1161\/01.STR.0000109767.11426.17","article-title":"Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study","volume":"35","author":"Kleindorfer","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB21","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00004647-199907000-00008","article-title":"Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat","volume":"19","author":"Kuroda","year":"1999","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB22","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2165\/00023210-200115110-00001","article-title":"Reducing bleeding complications after thrombolytic therapy for stroke: clinical potential of metalloproteinase inhibitors and spin trap agents","volume":"15","author":"Lapchak","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1527-3458.2003.tb00252.x","article-title":"Development of the nitrone-based spin trap agent NXY-059 to treat acute ischemic stroke","volume":"9","author":"Lapchak","year":"2003","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/01.STR.32.1.147","article-title":"Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6, 6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: combination studies with the thrombolytic tissue plasminogen activator","volume":"32","author":"Lapchak","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB25","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1161\/01.STR.0000017145.22806.AA","article-title":"Effects of the spin trap agent disodium-[tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit Large clot embolic stroke model: combination studies with tissue plasminogen activator","volume":"33","author":"Lapchak","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB26","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/01.STR.0000015346.00054.8B","article-title":"Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator","volume":"33","author":"Lapchak","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB56","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.expneurol.2004.02.005","article-title":"Coadministration of NXY-059 and tenecteplase six hours following embolic strokes in rabbits improves clinical rating scores","volume":"188","author":"Lapchak","year":"2004","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB27","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/01.STR.32.3.675","article-title":"Tolerability and pharmacokinetics of the nitrone NXY-059 in patients with acute stroke","volume":"32","author":"Lees","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB28","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1161\/01.STR.0000053032.14223.81","article-title":"Tolerability of NXY-059 at higher target concentrations in patients with acute stroke","volume":"34","author":"Lees","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB29","first-page":"246","article-title":"Pilot study of tenecteplase (TNK) in acute stroke: preliminary report","volume":"34","author":"Lyden","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB30","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1126\/science.1090270","article-title":"Stroke: tPA and the clinic","volume":"301","author":"Marler","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB31","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1161\/01.STR.32.1.190","article-title":"NXY-059, a free radical-trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate species","volume":"32","author":"Marshall","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB32","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1161\/01.STR.0000087790.79851.A8","article-title":"Functional and histological evidence for the protective effect of NXY-059 in a primate model of stroke when given 4 hours after occlusion","volume":"34","author":"Marshall","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0006-8993(03)02511-3","article-title":"Comparison of the neuroprotective effect of clomethiazole, AR-R15896AR and NXY-059 in a primate model of stroke using histological and behavioural measures","volume":"972","author":"Marshall","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB34","first-page":"5","article-title":"Iron, free radicals, and oxidative injury","volume":"35","author":"McCord","year":"1998","journal-title":"Semin. Hematol"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB35","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/jama.289.11.1363","article-title":"Tensions remain over tPA for stroke","volume":"289","author":"Mitka","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB36","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group","volume":"333","year":"1995","journal-title":"N. Engl. J Med"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB37","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1136\/heart.89.11.1358","article-title":"Thrombolysis: newer thrombolytic agents and their role in clinical medicine","volume":"89","author":"Nordt","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB38","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0006-8993(99)02010-7","article-title":"Effects of combined postischemic hypothermia and delayed N-tert-butyl-alpha-pheylnitrone (PBN) administration on histopathological and behavioral deficits associated with transient global ischemia in rats","volume":"846","author":"Pazos","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0006-8993(98)00253-4","article-title":"Protective effects of free radical inhibitors in intracerebral hemorrhage in rat","volume":"795","author":"Peeling","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1749-6632.2001.tb05632.x","article-title":"Protein oxidation in aging and age-related diseases","volume":"928","author":"Stadtman","year":"2001","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB41","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/03602539808996310","article-title":"Reactive oxygen-mediated protein oxidation in aging and disease","volume":"30","author":"Stadtman","year":"1998","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB42","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1161\/01.STR.25.10.2072","article-title":"A long-half-life and fibrin-specific form of tissue plasminogen activator in rabbit models of embolic stroke and peripheral bleeding","volume":"25","author":"Thomas","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB43","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0002-9343(00)00380-6","article-title":"Third-generation thrombolytic drugs","volume":"109","author":"Verstraete","year":"2000","journal-title":"Am. J. Med"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB44","series-title":"Neuroprotection","first-page":"471","article-title":"Hemorrhagic stroke: pathophysiological mechanisms and neuroprotective treatments","author":"Wagner","year":"2001"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB45","article-title":"Local brain hypothermia for neuroprotection in stroke treatment and aneurysm repair","author":"Wagner","year":"2004","journal-title":"Neurol. Res"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB46","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/01.STR.27.3.490","article-title":"Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matter","volume":"27","author":"Wagner","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB47","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000065703","article-title":"Protein oxidation and heme oxygenase-1 induction in porcine white matter following intracerebral infusions of whole blood or plasma","volume":"24","author":"Wagner","year":"2002","journal-title":"Dev. Neurosci"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB48","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/01.WCB.0000073905.87928.6D","article-title":"Heme and iron metabolism: role in cerebral hemorrhage","volume":"23","author":"Wagner","year":"2003","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1385\/MN:28:3:229","article-title":"Triggers and mediators of hemorrhagic transformation in cerebral ischemia","volume":"28","author":"Wang","year":"2003","journal-title":"Mol. Neurobiol"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB50","first-page":"118","article-title":"Society for Academic Emergency Medicine (SAEM) Neurologic Emergencies Interest Group response to the SAEM board position on optimizing care of the stroke patient\u2014in reply","volume":"11","author":"Yealy","year":"2004","journal-title":"Acad. Emerg. Med"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB51","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1161\/01.STR.0000083622.65684.21","article-title":"Combination drug therapy and mild hypothermia after transient focal cerebral ischemia in rats","volume":"34","author":"Zausinger","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0006-8993(00)02693-7","article-title":"Postischemic intracarotid treatment with TNK-tPA reduces infarct volume and improves neurological deficits in embolic stroke in the unanesthetized rat","volume":"878","author":"Zhang","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB53","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2174\/1566524033479717","article-title":"Stroke: molecular mechanisms and potential targets for treatment","volume":"3","author":"Zheng","year":"2003","journal-title":"Curr. Mod. Med"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB54","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1212\/WNL.53.1.14","article-title":"Thrombolytic stroke therapy: past, present, and future","volume":"53","author":"Zivin","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2004.05.006_BIB55","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/01.STR.23.5.767","article-title":"Quantal bioassay and stroke","volume":"23","author":"Zivin","year":"1992","journal-title":"Stroke"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488604001785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488604001785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:40:49Z","timestamp":1762148449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488604001785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0014488604001785"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2004.05.006","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extending the window for acute stroke treatment: thrombolytics plus CNS protective therapies","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2004.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2004.02.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}